These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22817666)

  • 21. Frequency and etiology of tubulo-interstitial nephritis in an adult renal biopsies in a tertiary renal care hospital: A single-center study.
    Qureshi R; Imtiaz S; Dhrolia M; Ahmad A
    Saudi J Kidney Dis Transpl; 2020; 31(2):335-341. PubMed ID: 32394905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
    Koda R; Watanabe H; Tsuchida M; Iino N; Suzuki K; Hasegawa G; Imai N; Narita I
    BMC Nephrol; 2018 Feb; 19(1):48. PubMed ID: 29486725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination Cyclophosphamide/Glucocorticoids Provide Better Tolerability and Outcomes versus Glucocorticoids Alone in Patients with Sjogren's Associated Chronic Interstitial Nephritis.
    Shen Y; Xie J; Lin L; Li X; Shen P; Pan X; Ren H; Chen N
    Am J Nephrol; 2017; 46(6):473-480. PubMed ID: 29241210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury.
    Hatakeyama Y; Horino T; Matsumoto T; Terada Y; Okuhara Y
    Clin Exp Nephrol; 2021 Oct; 25(10):1087-1092. PubMed ID: 34089392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.
    Broder A; Mowrey WB; Khan HN; Jovanovic B; Londono-Jimenez A; Izmirly P; Putterman C
    Semin Arthritis Rheum; 2018 Feb; 47(4):545-551. PubMed ID: 28803673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute interstitial nephritis - a reappraisal and update.
    Raghavan R; Eknoyan G
    Clin Nephrol; 2014 Sep; 82(3):149-62. PubMed ID: 25079860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated glomerular filtration rate and daily amount of urinary protein predict the clinical remission rate of tonsillectomy plus steroid pulse therapy for IgA nephropathy.
    Suzuki K; Miura N; Imai H
    Clin Exp Nephrol; 2014 Aug; 18(4):606-12. PubMed ID: 24052158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience.
    Mamlouk O; Selamet U; Machado S; Abdelrahim M; Glass WF; Tchakarov A; Gaber L; Lahoti A; Workeneh B; Chen S; Lin J; Abdel-Wahab N; Tayar J; Lu H; Suarez-Almazor M; Tannir N; Yee C; Diab A; Abudayyeh A
    J Immunother Cancer; 2019 Jan; 7(1):2. PubMed ID: 30612580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction.
    Saeki T; Kawano M; Mizushima I; Yamamoto M; Wada Y; Ubara Y; Nakashima H; Ito T; Yamazaki H; Narita I; Saito T
    Clin Exp Nephrol; 2016 Feb; 20(1):87-93. PubMed ID: 26141243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic roles of urinary kidney injury molecule 1 and soluble C5b-9 in acute tubulointerstitial nephritis.
    Zhao WT; Huang JW; Sun PP; Su T; Tang JW; Wang SX; Liu G; Yang L
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F584-F592. PubMed ID: 31291122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tubulointerstitial nephritis and uveitis syndrome (TINU) with Fanconi's syndrome.
    Yao YH; Lin CC; Chung YM; Yang AH; Li SY; Lin CC; Lin YP; Yang WC; Yang CY
    Clin Nephrol; 2011 Feb; 75 Suppl 1():75-8. PubMed ID: 21269599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presentation, diagnosis, and treatment outcome of tuberculous-mediated tubulointerstitial nephritis.
    Chapagain A; Dobbie H; Sheaff M; Yaqoob MM
    Kidney Int; 2011 Mar; 79(6):671-677. PubMed ID: 21160461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased prevalence of acute tubulointerstitial nephritis.
    Goicoechea M; Rivera F; López-Gómez JM;
    Nephrol Dial Transplant; 2013 Jan; 28(1):112-5. PubMed ID: 22759386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pathomorphology of acute drug-induced tubulointerstitial nephritis].
    Pospishil' IuO
    Lik Sprava; 1996; (5-6):94-6. PubMed ID: 9377413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevation of erythrocyte sedimentation rate and C-reactive protein levels reflects renal interstitial inflammation in drug-induced acute tubulointerstitial nephritis.
    Zheng XZ; Gu YH; Su T; Zhou XJ; Huang JW; Sun PP; Jia Y; Xu DM; Wang SX; Liu G; Yang L
    BMC Nephrol; 2020 Nov; 21(1):514. PubMed ID: 33243164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults: A national retrospective strobe-compliant study.
    Legendre M; Devilliers H; Perard L; Groh M; Nefti H; Dussol B; Trad S; Touré F; Abad S; Boffa JJ; Frimat L; Torner S; Seidowsky A; Massy ZA; Saadoun D; Rieu V; Schoindre Y; Heron E; Frouget T; Lionet A; Glowacki F; Arnaud L; Mousson C; Besancenot JF; Rebibou JM; Bielefeld P
    Medicine (Baltimore); 2016 Jun; 95(26):e3964. PubMed ID: 27367994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids.
    Prendecki M; Tanna A; Salama AD; Tam FW; Cairns T; Taube D; Cook HT; Ashby D; Duncan ND; Pusey CD
    Clin Kidney J; 2017 Apr; 10(2):233-239. PubMed ID: 28396740
    [No Abstract]   [Full Text] [Related]  

  • 39. Prednisone in the treatment of tubulointerstitial nephritis in children.
    Jahnukainen T; Saarela V; Arikoski P; Ylinen E; Rönnholm K; Ala-Houhala M; Nuutinen M
    Pediatr Nephrol; 2013 Aug; 28(8):1253-60. PubMed ID: 23605375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis.
    Lin JS; Mamlouk O; Selamet U; Tchakarov A; Glass WF; Sheth RA; Layman RM; Dadu R; Abdelwahab N; Abdelrahim M; Diab A; Yee C; Abudayyeh A
    Oncoimmunology; 2021 Feb; 10(1):1877415. PubMed ID: 33643693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.